| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, College of Medicine, The Milton S. Hershey Medical Center of The Pennsylvania State University, Hershey, Pennsylvania 17033
Experiments on the inhibition of the replication of herpes simplex virus types 1 and 2 in human embryonic kidney and primary rabbit kidney cells by cytosine arabinoside have shown that synthesis of infectious herpes simplex virus type 1 is 2 to 3 times more sensitive to the analog than that of type 2. With labeled analog, it appears that the relatively greater concentrations of cytosine arabinoside necessary in hamster embryo fibroblast cells, compared with rabbit cells, is probably due to the less efficient uptake of the analog by these cells. Isopycnic cesium chloride centrifugations of Sarkosyl-Pronase digests of cells have shown that cytosine arabinoside may be incorporated into herpesvirus DNA as well as into cellular DNA, the uptake into the DNA of herpes simplex virus type 2 being somewhat greater than that of type 1.
1 This study was conducted, in part, under Contract 70-2024 within the Special Virus Cancer Program of the National Cancer Institute, NIH, USPHS, and Grant PS-59 from the American Cancer Society.
Received 8/18/72. Accepted 10/11/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |